340B covered entities will get none of the $75 million Bristol Myers Squibb is paying California, 27 other states, and the federal government to settle claims it underreported its average manufacturer prices (AMPs) in order to underpay Medicaid drug rebates.
California Attorney General Rob Bonta’s office confirmed yesterday that no proceeds of the settlement will be going to 340B covered entities. Bonta issued a statement about the terms of the settlement on Tuesday. The U.S. Justice Department announced in April that BMS had agreed to pay the federal and state governments to resolve the allegations against it.
340B covered entities will get none of the $75 million Bristol Myers Squibb is paying California, 27 other states, and the federal government to settle claims it underreported its average manufacturer prices (AMPs) in order to underpay Medicaid drug rebates.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
